Towards Healthcare
Next-Generation Therapy Market 2025 Growth Drives 38% Gene Therapy Share

Next-Generation Therapy Market 2025 Update: WuXi Biologics, AbbVie & Dyno Drive Breakthrough Innovations

The next-generation therapy market is expanding due to increasing use of cell and gene therapies as well as rising developments in RNA-based therapies. North America led the market due to the robust industries.

Content

  • Insight Code: 5823
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

Tech advances and consumer trends drive strong growth in the next-generation therapies market through 2034.

North America is currently leading the next-generation therapy market due to the presence of robust industries.

The next-generation therapy market includes six segments such as by therapy type, Shape, Picture by application, Shape, Picture by vector type, by route of administration, by end user, and by region.

Some key players include Novartis AG, Gilead Sciences (Kite Pharma), Spark Therapeutics (Roche), and Bluebird Bio.

Key trends include growth in the development of next-generation therapies and innovation in small interfering RNA (siRNA) therapeutics.

Gene therapy, cell therapy, RNA-based therapy, and genome editing are the types of next-generation therapies.

Increasing use of cell and gene therapies is the factor that drives the market.

American Society of Gene & Cell Therapy (ASGCT), Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions